Article
registration form
Survey highlights gender and racial disparities in ophthalmology
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Beacon Therapeutics announces positive 3-month data from Phase 2 DAWN trial of AGTC-501 in patients with X-linked retinitis pigmentosa
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
New study highlights retinopathy risk from hair dye use
Generative AI: It’s only just begun